"The test will require
FDA approval before it can move beyond clinical testing.Pathologists and oncologists already have a test, called
CellSearch, that’s used to look for CTCs (ci
rculating tumor cells). But Kuhn says physicians need a test that is far more sensitive, and thus more useful for a wide array of cancer patients."
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.